The US FDA has established a green list of imported GLP 1 drug ingredients deemed safe and allowed into the country, while keeping out those from unverified foreign sources. The agency had identified The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and commercialization Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives Compounded "semaglutide" is not FDA approved semaglutide.com Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law